Top 10 Major Companies in the Romania Pleurisy Market | Competitive Landscape 2026

Romania Pleurisy Market Overview

According to 6Wresearch, the market for Pleurisy in Romania is expected to rise, driven by an increase in the occurrence of respiratory infections, pneumonia, and tuberculosis, along with a rise in the awareness of the benefits of early intervention as a treatment. Pleurisy is known as an inflammation of the pleura, which is the membranes surrounding the lungs.

The market is driven by the growing ageing population, upgraded accessibility of healthcare, and the rising awareness of chronic diseases, which include respiratory ailments. Furthermore, the increase in healthcare expenditure, as well as the government's support for the drug industry through the National Health Insurance House, is expected to be beneficial for the market's growth.

Competitive Landscape

The competitive landscape of the Romania Pleurisy industry is dominated by drug manufacturers with a longstanding market presence, as well as domestic companies that offer cost-effective products. The market players have managed to establish themselves in the market with the help of quality products, and R&D for new forms of anti-inflammatory and antibiotic treatments.

Below is a list of leading players operating in the Romania Pleurisy Market:

1. Zentiva Romania

Zentiva is a leader in the Romanian generic market, providing a vast range of anti-inflammatory and respiratory medicines essential for treating pleural inflammation.

2. Terapia S.A. (Sun Pharma Company)

Terapia is the largest local manufacturer in Romania, producing advanced antibiotics and analgesics used extensively in hospital settings for respiratory complications.

3. Antibiotice Iași

Antibiotice Iași is a state-controlled company and a top producer of anti-infective agents, including injectable treatments for pneumonia-related pleurisy.

4. Biofarm S.A.

Biofarm is one of the oldest Romanian manufacturers, offering a diverse portfolio of respiratory and ENT medications to manage inflammation.

5. Gedeon Richter Romania

A vertically integrated pharmaceutical player that manufactures and distributes high-quality respiratory products across the Romanian territory.

6. Sandoz Romania

Sandoz maintains a strong presence in Romania with an extensive respiratory portfolio focusing on pneumonia and allergy-related pleural conditions.

7. GlaxoSmithKline (GSK) Romania

GSK is a global leader in respiratory health, providing innovative inhalers and systemic treatments for lung and pleural diseases in Romania.

8. Sanofi Romania

Sanofi provides a broad range of pharmaceutical solutions, including specialized anti-inflammatory treatments and vaccines to prevent respiratory infections.

9. AstraZeneca Romania

AstraZeneca focuses heavily on respiratory and immunology, offering next-generation therapies for patients suffering from severe pulmonary conditions.

10. Pfizer Romania

Pfizer remains a critical player in the market by supplying high-efficacy antibiotics and vaccines that target the underlying causes of pleuritic inflammation.